Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × fenofibric acid × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Medulloblastoma 1 Ependymoma 1

Interventions

Magnetic Resonance Spectroscopy 97 Specimen Handling 92 pembrolizumab 89 Cyclophosphamide 87 Radiotherapy 74 Biopsy 68 venetoclax 63 Nivolumab 54 Carboplatin 49 Cisplatin 45 fludarabine 44 Dexamethasone 44 Radiosurgery 43 Standard of Care 40 Blood Specimen Collection 40 Paclitaxel 38 Rituximab 37 Drug Therapy 37 Surveys and Questionnaires 35 Azacitidine 35 Bevacizumab 34 Oxaliplatin 33 Gemcitabine 32 Radiation 30 Cytarabine 30 durvalumab 29 Ipilimumab 29 X-Rays 28 fludarabine phosphate 27 Fluorouracil 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡